Arixtra

Product
Active substances: fondaparinux sodium. Therapeutic area: Venous Thrombosis;Pulmonary Embolism;Myocardial Infarction;Angina, Unstable. ATC code: B01AX05
Reason
Quality defect
Classification
Class I
Category
drug recall
Country
European Union
Agency
EMA-DHPC
Recall date
2026-02-06
Status
Ongoing
Distribution
European Union

Official recall notice from EMA-DHPC

Recall details on Nibble Recalls: https://trynibble.app/recalls/8f8141ee-8100-4f77-97a8-36bfb5eb539d